Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, NH- 58, Uttar Pradesh, 250002, India.
Drug Deliv. 2011 Feb;18(2):97-110. doi: 10.3109/10717544.2010.520354. Epub 2010 Oct 20.
In the present era, gastroretentive dosage forms (GRDF) receive great attention because they can improve the performance of controlled release systems. An optimum GRDF system can be defined as a system which retains in the stomach for a sufficient time interval against all the physiological barriers, releases active moiety in a controlled manner, and finally is easily metabolized in the body. Physiological barriers like gastric motility and gastric retention time (GRT) act as obstacles in developing an efficient GRDF. Gastroretention can be achieved by developing different systems like high density systems, floating drug delivery systems (FDDS), mucoadhesive systems, expandable systems, superporous systems, and magnetic systems. All these systems have their own merits and demerits. This review focused on the various aspects useful in development of GRDF including the current trends and advancements.
在当今时代,胃滞留剂型(GRDF)受到了极大的关注,因为它们可以改善控释系统的性能。一个最佳的 GRDF 系统可以被定义为一个在胃中保留足够时间间隔以抵抗所有生理障碍的系统,以控制方式释放有效成分,最后在体内很容易被代谢。像胃动力和胃滞留时间(GRT)这样的生理障碍是开发有效 GRDF 的障碍。通过开发不同的系统,如高密度系统、漂浮药物递送系统(FDDS)、黏膜粘附系统、可膨胀系统、超多孔系统和磁系统,可以实现胃滞留。所有这些系统都有其自身的优点和缺点。本综述重点介绍了开发 GRDF 的各个方面,包括当前的趋势和进展。